Diferencia entre revisiones de «Intralipid»

Sin resumen de edición
(Switch SMW query from broadtable to table format for better layout with TOC)
 
(No se muestran 33 ediciones intermedias de 11 usuarios)
Línea 1: Línea 1:
==General==
==General==
*Type: Lipid emulsion
*Type: Lipid emulsion therapy
*Dosage Forms: 20% fat emulsion
*Dosage Forms: 10%, 20%, and 30% lipid emulsions
**Note that 20% is used for lipid rescue therapy for systemic drug toxicity<ref>http://www.lipidrescue.org/</ref>
*Routes of Administration: IV
*Routes of Administration: IV
*Common Trade Names: Intralipid
*Common Trade Names: Intralipid, Lipid Rescue <ref>http://www.lipidrescue.org/</ref>


==Adult Dosing==
==Adult Dosing==
*1.5 ml/kg bolus<ref>Cave, G. Intravenous Lipid Emulsion as Antidote Beyond Local Anesthetic Toxicity: A Systematic Review. 2009. 16(9)815–824</ref>
Note that dosing for adults and children is not standardized but is based on case reports and recommendations<ref>http://www.lipidrescue.org/</ref>
**Followed by 0.25 ml/kg/min for 20 min or until hemodynamic stability is achieved.<ref>Dillane D, Finucane BT. Local anesthetic systemic toxicity. Can J Anaesth. 2010 Apr;57(4):368-80.</ref>
 
*1.5 mL/kg bolus over 1 minute<ref>Cave, G. Intravenous Lipid Emulsion as Antidote Beyond Local Anesthetic Toxicity: A Systematic Review. 2009. 16(9)815–824</ref><ref>https://canadiem.org/iv-lipid-emulsion-for-drug-toxicity-in-the-ed/</ref>
**Note that dosing is based on lean or ideal body mass<ref>https://canadiem.org/iv-lipid-emulsion-for-drug-toxicity-in-the-ed/</ref>
**Followed by 0.25 mL/kg/min for 20 min or until hemodynamic stability is achieved.<ref>Dillane D, Finucane BT. Local anesthetic systemic toxicity. Can J Anaesth. 2010 Apr;57(4):368-80.</ref>
 
===Persistent Cardiovascular Collapse===
*May repeat bolus once or twice for persistent cardiovascular collapse<ref>http://www.lipidrescue.org/</ref>
*May double rate of infusion to 0.5 mL/kg/min for persistent hypotension<ref>http://www.lipidrescue.org/</ref>
*Max cumulative dose: 12 ml/kg
 
===After Cardiovascular Stability Achieved===
*Maintain infusion for at least 10 minutes<ref>http://www.lipidrescue.org/</ref>
 
===Simplified Protocol<ref>https://canadiem.org/iv-lipid-emulsion-for-drug-toxicity-in-the-ed/</ref>===
*Based on 'average' 70 kg patient
**100 mL IV bolus over 1 minute
**Infusion at 18 mL/h IV


==Pediatric Dosing==
==Pediatric Dosing==


As with adults, pediatric dosing is not standardized<ref>http://www.lipidrescue.org/</ref>
*Initial bolus of 0.8 - 3 mL/kg<ref>Lipid emulsion (conventional, soybean oil-based): Drug information. Uptodate. Accessed May 15 2019.</ref>
*No recommendations provided for rate of ongoing infusion


==Special Populations==
==Special Populations==
Línea 21: Línea 42:
**Adult
**Adult
**Pediatric
**Pediatric
==Emergency department indications<ref>http://www.lipidrescue.org/</ref><ref>https://canadiem.org/iv-lipid-emulsion-for-drug-toxicity-in-the-ed/</ref>==
*Severe systemic drug toxicity plus:
**Persistent hemodynamic instability
**All conventional options have been exhausted
**Toxicity has poor prognosis
*Common toxicities
**[[Local anesthetic systemic toxicity]]
**[[Beta blocker]]
**[[Calcium Channel Blocker]]
**[[TCA]]
**[[Bupropion]]


==Contraindications==
==Contraindications==
Línea 27: Línea 60:
==Adverse Reactions==
==Adverse Reactions==
===Serious===
===Serious===
*Asystole (case reported) <ref>Cole JB et al. Asystole immediately following intravenous fat emulsion for overdose. J Med Toxicol. 2014;10(3)307-310</ref>
*Fat embolism
*Hypersensitivity reactions
*ARDS


===Common===
===Common===
 
*[[Pancreatitis]]<ref name = review> Kostic MA and Gorelick M. Review of the use of lipid emulsion in nonlocal anesthetic poisoning. Pediatric Emergency Care 2014;30:427-436</ref>
*Hypertriglyceridemia<ref name=review></ref>
*Interferes with some lab measurements
**Glucose and magnesium concentrations become inaccurate
**Creatinine and lipase become unmeasurable


==Pharmacology==
==Pharmacology==
Línea 36: Línea 77:
*Excretion:  
*Excretion:  
*Mechanism of Action:
*Mechanism of Action:
**Unclear, but proposed mechanisms include<ref>https://canadiem.org/iv-lipid-emulsion-for-drug-toxicity-in-the-ed/</ref>:
***Lipid sink/partition
****Emulsion surrounds lipophilic drug molecule, partitioning it from target organs
***Cardiac metabolism
****Fatty acids provide the myocardium with a ready energy source, improving cardiac contractility


==Comments==
*Avoid co-administration of:<ref>http://www.lipidrescue.org/</ref>
**[[Vasopressin]]
**[[Calcium channel blockers]]
**[[Beta-blockers]]
**[[Local anesthetics]]
**High-dose [[epinephrine]]
**[[Propofol]]


==Comments==


==Indications by Condition==
''The following table is automatically generated from disease/condition pages across WikEM.''
{{#ask:[[Has DrugName::Intralipid]]
|?Has Indication=Indication
|?Has Dose=Dose
|?Has Context=Context
|?Has Route=Route
|?Has Population=Population
|format=table
|headers=plain
|mainlabel=-
|sort=Has Indication
|limit=50
}}


==See Also==
==See Also==
*[[Beta-blocker toxicity]]
*[[Beta-blocker toxicity]]
*[[Calcium channel blocker toxicity]]
*[[Local Anesthetic Systemic Toxicity (LAST)]]
*[[Local Anesthetic Systemic Toxicity (LAST)]]
*[[Tricyclic antidepressant toxicity]]


==External Links==
==External Links==
Línea 51: Línea 121:
<references/>
<references/>


[[Category:Drugs]]
[[Category:Pharmacology]]
[[Category:Tox]]
[[Category:Toxicology]]

Revisión actual - 21:56 20 mar 2026

General

  • Type: Lipid emulsion therapy
  • Dosage Forms: 10%, 20%, and 30% lipid emulsions
    • Note that 20% is used for lipid rescue therapy for systemic drug toxicity[1]
  • Routes of Administration: IV
  • Common Trade Names: Intralipid, Lipid Rescue [2]

Adult Dosing

Note that dosing for adults and children is not standardized but is based on case reports and recommendations[3]

  • 1.5 mL/kg bolus over 1 minute[4][5]
    • Note that dosing is based on lean or ideal body mass[6]
    • Followed by 0.25 mL/kg/min for 20 min or until hemodynamic stability is achieved.[7]

Persistent Cardiovascular Collapse

  • May repeat bolus once or twice for persistent cardiovascular collapse[8]
  • May double rate of infusion to 0.5 mL/kg/min for persistent hypotension[9]
  • Max cumulative dose: 12 ml/kg

After Cardiovascular Stability Achieved

  • Maintain infusion for at least 10 minutes[10]

Simplified Protocol[11]

  • Based on 'average' 70 kg patient
    • 100 mL IV bolus over 1 minute
    • Infusion at 18 mL/h IV

Pediatric Dosing

As with adults, pediatric dosing is not standardized[12]

  • Initial bolus of 0.8 - 3 mL/kg[13]
  • No recommendations provided for rate of ongoing infusion

Special Populations

Emergency department indications[14][15]

Contraindications

  • Allergy to class/drug

Adverse Reactions

Serious

  • Asystole (case reported) [16]
  • Fat embolism
  • Hypersensitivity reactions
  • ARDS

Common

  • Pancreatitis[17]
  • Hypertriglyceridemia[17]
  • Interferes with some lab measurements
    • Glucose and magnesium concentrations become inaccurate
    • Creatinine and lipase become unmeasurable

Pharmacology

  • Half-life:
  • Metabolism:
  • Excretion:
  • Mechanism of Action:
    • Unclear, but proposed mechanisms include[18]:
      • Lipid sink/partition
        • Emulsion surrounds lipophilic drug molecule, partitioning it from target organs
      • Cardiac metabolism
        • Fatty acids provide the myocardium with a ready energy source, improving cardiac contractility

Comments


Indications by Condition

The following table is automatically generated from disease/condition pages across WikEM.

IndicationDoseContextRoutePopulation
Beta-blocker toxicity1.5 mL/kg IV bolus of 20%, then 0.25 mL/kg/min for 30-60 minLipid emulsion therapyIV/IV dripAdult
Calcium channel blocker toxicity1.5 mL/kg IV bolus of 20% lipid, then 0.25 mL/kg/minLipid emulsion therapyIV/IV dripAdult
Local anesthetic systemic toxicity1.5 mL/kg IV bolus over 1 min, then 0.25 mL/kg/min x20 min (increase to 0.5 mL/kg/min if declining)Lipid emulsion therapy (20% solution)IV/IV dripAdult

See Also

External Links

References

  1. ↑ http://www.lipidrescue.org/
  2. ↑ http://www.lipidrescue.org/
  3. ↑ http://www.lipidrescue.org/
  4. ↑ Cave, G. Intravenous Lipid Emulsion as Antidote Beyond Local Anesthetic Toxicity: A Systematic Review. 2009. 16(9)815–824
  5. ↑ https://canadiem.org/iv-lipid-emulsion-for-drug-toxicity-in-the-ed/
  6. ↑ https://canadiem.org/iv-lipid-emulsion-for-drug-toxicity-in-the-ed/
  7. ↑ Dillane D, Finucane BT. Local anesthetic systemic toxicity. Can J Anaesth. 2010 Apr;57(4):368-80.
  8. ↑ http://www.lipidrescue.org/
  9. ↑ http://www.lipidrescue.org/
  10. ↑ http://www.lipidrescue.org/
  11. ↑ https://canadiem.org/iv-lipid-emulsion-for-drug-toxicity-in-the-ed/
  12. ↑ http://www.lipidrescue.org/
  13. ↑ Lipid emulsion (conventional, soybean oil-based): Drug information. Uptodate. Accessed May 15 2019.
  14. ↑ http://www.lipidrescue.org/
  15. ↑ https://canadiem.org/iv-lipid-emulsion-for-drug-toxicity-in-the-ed/
  16. ↑ Cole JB et al. Asystole immediately following intravenous fat emulsion for overdose. J Med Toxicol. 2014;10(3)307-310
  17. ↑ 17.0 17.1 Kostic MA and Gorelick M. Review of the use of lipid emulsion in nonlocal anesthetic poisoning. Pediatric Emergency Care 2014;30:427-436
  18. ↑ https://canadiem.org/iv-lipid-emulsion-for-drug-toxicity-in-the-ed/
  19. ↑ http://www.lipidrescue.org/
Obtenido de «https://www.wikem.org/w/index.php?title=Intralipid&oldid=387445»